Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The role of regulatory T cells in neurodegenerative diseases.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
A case of septal panniculitis secondary to interferon treatment.
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
Erythrocyte membrane Fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.
[American Academy of Neurology, Washington, 18-25 April 2015].
Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation.
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided).
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
Towards programming immune tolerance through geometric manipulation of phosphatidylserine.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation.
Gateway to wellness: an occupational therapy collaboration with the national multiple sclerosis society.
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
Extracting quantitative measures from EAP: a small clinical study using BFOR.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton.
Anatomical Brain Networks on the Prediction of Abnormal Brain States.
Pages
« first
‹ previous
…
193
194
195
196
197
198
199
200
201
…
next ›
last »